8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Quest Diagnostics ($DGX) filed a Form 8‑K on Jan 12, 2026 — Item 9.01 lists Exhibit 99.1: Presentation…
Filed with the SEC on · Summarized by InvestorsBot
Quest Diagnostics ($DGX) filed a Form 8‑K on Jan 12, 2026 — Item 9.01 lists Exhibit 99.1: Presentation dated Jan 12, 2026, and Exhibit 104: cover page in Inline XBRL. Signed by Sean D. Mersten, VP & Corporate Secretary. 📄 #QuestDiagnostics #Healthcare
The material attachment is Exhibit 99.1 (Jan 12, 2026 presentation) — investors should review it for any corporate/operational updates. No additional financial statements disclosed under Item 9.01. 🧾 $DGX #QuestDiagnostics #Diagnostics